申请人:McCall John M.
公开号:US20140128392A1
公开(公告)日:2014-05-08
Disclosed herein are new heterocyclic compounds of Formula IIa:
and compositions thereof, and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
本文披露了新的Formula IIa的杂环化合物及其组合物,以及它们作为治疗疾病的药物的应用。还提供了在人类或动物主体中抑制PAS激酶(PASK)活性的方法,用于治疗糖尿病等疾病。